A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients ...

The new test, called the risk of ovarian cancer algorithm (Roca), calculates a woman’s individual risk based on factors such ...

Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.